Advertisement
The award was presented to Dr. Yang in recognition of proposed researchtitled, "A Feasibility Study of Establishing a Web-based Women's Health Portaland Information System." The purpose of the Feasibility Study is to definefeatures and functionality of a Women's Health Portal, conceived byQualityMetric to be an interactive and educational healthcare experienceserving consumers, clinicians, and other stakeholders who seek relevantinformation on women's health, including PMS/PMDD. The Women's Health Portalwill incorporate patient-reported outcome (PRO) measures developed byQualityMetric, including disease/condition screening tools and surveys thatassess and monitor overall health status, also referred to as health-relatedquality of life (HRQOL), of women over time, individually and in aggregate.
Advertisement
"We are extremely proud of Dr. Yang's research accomplishments and excitedabout the opportunity a Women's Health Portal will present to healthcare,"commented James E. Dewey, PhD, QualityMetric's Chief Innovation and ResearchOfficer. "We appreciate the recognition of ACOG and Bayer, and look forward toan ongoing collaboration on Portal development and implementation," Deweyadded.
The Feasibility Study will start with the Premenstrual Symptoms ImpactSurvey (PMSIS), developed by QualityMetric scientists as a screening tool toassess the effects of premenstrual symptoms on daily life. The PMSIS will alsobe used to determine whether the impact of premenstrual symptoms warrant adoctor's visit. Recent literature has shown that the HRQOL impact of PMSand/or PMDD can be substantial in both physical and mental health domains. Forexample, the impact to physical health can be comparable to conditions such asosteoarthritis and rheumatoid arthritis. A manuscript citing the developmentand validation of the PMSIS was published in the 2008 March issue of theJournal of Women's Health.
A data repository is also being considered for QualityMetric's Women'sHealth Portal which would provide health status information beneficial tomultiple stakeholders, including consumers/women, healthcare providers,managed care organizations, pharmaceutical companies, payors and decisionmakers in government, advocacy and health policy. "The Women's Health Portal,as it is being considered by ACOG and Bayer, reflects an innovation in thecare and treatment of PMS/PMDD as well as other women's health issues," notedDr. Yang. "Involving women in their own care and treatment by providing usefuland instructive outcomes information is timely and relevant as we struggle toquantify health outcomes with costs and to meaningfully engage the consumer inadherence and compliance of new treatments," Yang concluded.
About QualityMetric Incorporated
QualityMetric works with the world's largest healthcare and life sciencescompanies to measure health outcomes. Our scientifically validated andstandardized consumer health surveys are used around the world to measure theeffectiveness of medical treatments and interventions, drugs and biologics,track health improvement or decline, screen populations for disease, andidentify future health risks. QualityMetric's patient-reported outcome (PRO)surveys provide scientifically valid assessments of both physical and mentalhealth. Our PROs include the SF-36v2(R), SF-12v2(R), and SF-8(TM) Health
